Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026)

Glaukos' (GKOS) quarterly Total Non-Current Liabilities came in at $192.9 million in Q1 2026, up 6.62% year-on-year from $180.9 million in Q1 2025, and down 6.17% on a QoQ basis from $205.6 million in Q4 2025.

Glaukos (GKOS) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Total Non-Current Liabilities data on file, last reported at $192.9 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 6.62% year-over-year to $192.9 million in Q1 2026; TTM through Mar 2026 was $192.9 million, a 6.62% increase from a year earlier, with the FY2025 full-year figure at $205.6 million, up 10.86% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $192.9 million, down from $205.6 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for GKOS reached as high as $482.6 million in Q1 2024 and fell as low as $180.9 million in Q1 2025.
  • Historically, Total Non-Current Liabilities has averaged $338.5 million across 5 years, with a median of $445.2 million in 2022.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 10.86% in 2025 and fell as far as 62.51% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $462.1 million in 2022, then grew by 0.61% to $464.9 million in 2023, then plunged by 60.11% to $185.5 million in 2024, then increased by 10.86% to $205.6 million in 2025, then fell by 6.17% to $192.9 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $192.9 million in Q1 2026, $205.6 million in Q4 2025, and $198.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn 192.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 192.91 Mn
Dec 31, 2025 205.59 Mn
Sep 30, 2025 198.75 Mn
Jun 30, 2025 191.07 Mn
Mar 31, 2025 180.93 Mn
Dec 31, 2024 185.45 Mn
Sep 30, 2024 235.95 Mn
Jun 30, 2024 233.84 Mn
Mar 31, 2024 482.61 Mn
Dec 31, 2023 464.90 Mn
Sep 30, 2023 458.18 Mn
Jun 30, 2023 455.02 Mn
Mar 31, 2023 452.89 Mn
Dec 31, 2022 462.10 Mn
Sep 30, 2022 450.42 Mn
Jun 30, 2022 459.35 Mn
Mar 31, 2022 445.18 Mn
Dec 31, 2021 453.05 Mn
Sep 30, 2021 454.10 Mn
Jun 30, 2021 450.82 Mn